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DHA ，即全顺式 -4, 7, 10, 13, 16, 19- 二十二碳六烯酸
(docosahexaenoic acid)，是一种具有重要生理意义和经济价值的多不






简单的优点，因此利用这类富含 DHA 的微生物通过发酵制备 DHA



















































2. 构建了过表达外源乙酰辅酶 A 合成酶基因的裂壶藻基因工程藻
株，并对该基因的功能进行了评价。从大肠杆菌中克隆获得了乙酰辅
酶 A 合成酶基因 ACS 基因；构建了 ACS 基因的表达模块，使得该
基因在 TEF1 启动子和 CYC1 终止子的控制之下；构建了 ACS 基因
过表达载体 p-ACS-418-18S, 以G418作为筛选标记和 18S rDNA部分
序列作为重组位点；通过电击遗传转化，将线性化载体导入裂壶藻体
内，并在 G418 抗性平板上筛选到一系列的阳性克隆；PCR 检测了阳
性克隆子中 ACS 基因的插入情况，表明大部分的具有 G418 抗性的
阳性克隆子中 ACS 基因已经成功的插入到裂壶藻的基因组中；通过

















































将 vgb 基因的表达模块连接进入双元载体 pCAMBIA2301,构建了重
组载体 pCAMBIA2301-vgb；将 vgb 基因通过农杆菌介导的转化方法




























DHA (docosahexaenoic acid) is a kind of polyunsaturated fatty acids 
(PUFA) with vital physiological functions and high economic value. 
Oceanic fish and fish oil products are the typical dietary sources of DHA. 
However, due to emerging concerns with sustainability of marine 
resources and with the levels of environmental contaminants in fish, 
major efforts have been made to identify or create alternative sources. 
Microorganisms have been developed as an alternative commercial 
source of oils enriched in DHA. 
Schizochytrium sp. is a microalga belonging to the Stramenopiles, a 
kingdom consisting of photosynthetic diatoms, brown algae and other 
algae commonly referred to as chromophytes. It can produce large 
amounts of oil (up to 55% of the cell dry weight) in which DHA can 
comprise as much as 35% of the total fatty acids. Schizochytrium sp. has 
been utilized for commercial production of DHA-rich oil and dried 
powder used as a source of DHA in foods, feeds, and nutritional 
supplements. 













has resulted in new strains with outstanding characteristics. Many 
genetically modified plants and actinomycetes have been used for 
commercial production. It is promising to explore genetically modified 
Schizochytrium with faster growth rate, higher fatty acid content and 
more simple compositions in the total fatty acid. Therefore, it is 
necessary and extremely important to increase the quality of 
Schizochytrium by genetic engineering strategy.  
In this study, we have developed two different genetic engineering 
strategies for the marine microalga Schizochytrium. One is the 
electroporation transformation method which mediated homologous 
recombination by 18S rDNA sequences. The other is Agrobacterium 
tumefaciens mediated transformation (ATMT) system which mediated 
illegitimate recombination. By these two methods, we successfully 
obtained Schizochytrium transformants in which fatty acid biosynthesis 
related genes were over-expressed. In summary, we have achieved the 
following results in this study. 
1. We investigated a novel transgene expression system in 
Schizochytrium by 18S rDNA-targeted homologous recombination. The 













respectively and the Zeocin was finally chosen as the selective marker for 
Schizochytrium transformation. The 18S rDNA sequence was cloned and 
used as the homologous site. We demonstrate the utility of 
electroporation as an efficient method for genetic transformation of 
Schizochytrium, and the electroporation conditions have been optimized. 
The PCR results indicated that exogenous gene Sh ble has successfully 
transferred into the Schizochytrium transformants. After then, the 
biomass and total lipid of transformants were characterized and 
compared with that of the wild type strain. The results suggested that the 
majority of the transformants showed similar biomass and total lipid with 
the wild type strain. Furthermore, the GC-MS results revealed that the 
transformants accumulated similar fatty acid compositions, indicating 
that homologous recombination at the 18S rDNA loci did not affect the 
fatty acid profile of Schizochytrium. The strategy described here makes it 
possible to explore genetically modified Schizochytrium to produce 
higher fatty acids and PUFAs.  
2. We cloned the acetyl-CoA synthetase (ACS) gene from E. coli and 
introduced it into Schizochytrium. The expression of exogenous acs gene 













terminator. The putative positive clones were picked and the 
incorporations of acs gene were determined by PCR analysis. The results 
demonstrated that the acs gene has incorporated into the genome for most 
of the G418-resistance Schizochytrium transformants. The RT-PCR 
results also indicated that the exogenous gene acs was transcribed 
successfully in the transformants A2 and A3. It should be noted that the 
biomass and fatty acid of the transformants A2 and A3 were significantly 
higher than that of the wild type strain. The GC-MS results demonstrated 
that transformants A2 and A3 showed similar fatty acid compositions 
with wild type strain. Our results demonstrated that applications of ACS 
gene in metabolic engineering of Schizochytrium improved the 
production of biomass and fatty acids significantly. 
3. We have developed a novel transformation approach of Schizochytrium 
using the Agrobacterium tumefaciens (A. tumefaciens) binary vector 
system. After co-cultivation of Schizochytrium protoplasts with A. 
tumefaciens harboring pCAMBIA2301 containing the neomycin 
phosphotransferase II (NPT II) gene as the selectable marker which 
confers resistance to G418, the Schizochytrium transformants were 













expression of the transgenes were confirmed by PCR analysis and GUS 
activity assay. To further validate the transformation system, 
pCAMBIA2301-EGFP containing the egfp gene was introduced into 
Schizochytrium. The following results demonstrated that the exogenous 
egfp gene has been successfully incorporated into the genome of 
Schizochytrium. In addition, the introduced egfp gene expressed 
efficiently according to the Western blot and fluorescence assay results. 
More importantly, the majority of the transformants displayed similar 
biomass and fatty acid production comparing with the wild type strain. 
Our results demonstrated that exogenous genes could be expressed 
efficiently in transgenic Schizochytrium, suggesting that genetically 
engineered Schizochytrium could be explored by this system. 
Finally, we introduced the Vitreoscilla hemoglobin gene (vgb) into 
Schizochytrium by the above-mentioned ATMT strategy. The insertion of 
the vgb gene was confirmed by PCR analysis. The results showed that the 
biomass of Schizochytrium transformants with expression of vgb gene 
increased dramatically in the hypoxic culture condition.  
Key words：Schizochytrium；DHA；genetic engineering；electroporation；
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1. 1 DHA 简介 
高度不饱和脂肪酸(Polyunsaturated fatty acids，PUFAs)是指含有两个或多个
顺式双键的 18 碳或 18 碳以上的长链脂肪酸。根据第一个不饱和双键在脂肪酸甲
基端的位置，高度不饱和脂肪酸可分为ω-3 和ω-6 两大类脂肪酸(图 1)。  
图 1ω-3 和ω-6 高度不饱和脂肪酸示意图 
常见的高度不饱和脂肪酸见表 1，其中 DHA 是主要的ω-3 高度不饱和脂肪
酸之一，具有各种重要的功能。DHA 是二十二碳六烯酸(Docosahexaenoic acid)
的英文缩写，其分子式为 C22H3202，分子量 328.48。结构式如下: 
 





















































乳哺育和为孕妇和婴幼儿补充适量的 DHA 被提倡和鼓励。2 基本结构成分 DHA
在大脑和视网膜组织的细胞膜中含量丰富。在视网膜的棒状外侧部分的细胞中，
DHA 可达细胞总脂的 60%以上；在人脑组织的细胞中，DHA 占总脂的 10%左右，
因此是人体视觉和神经系统细胞膜的重要组成成分。 
1.2.3 抗癌作用 
EPA 和 DHA 具有良好的免疫调节作用。研究表明，DHA 能促进 T 淋巴细
胞的增殖，提高细胞因子 TNF-2、IL-1β和 IL-6 的转录，而这细胞因子表达的提
高可以促进免疫系统的功能，从而提高免疫系统对肿瘤细胞的杀伤力[7]。另外，




EPA 和 DHA 具有抗炎症的作用。机理如下：花生四烯酸（AA）通过环氧
化酶可产生前列腺素（PGs），特别是 PGE2，是炎症发生的介质。同时，AA 还
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